7516.TWO Sea Mild Biotechnology Co., Ltd.
- Market cap
- TWD 143M
- P/E
- 21.1x
- P/B
- 1.34x
- ROE
- 8.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 7516.TWO undervalued?
Graham number7516.TWO trades 12.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sea Mild Biotechnology Co., Ltd. fundamental analysis
No fundamental analysis for Sea Mild Biotechnology Co., Ltd. yet.
Sea Mild Biotechnology Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sea Mild Biotechnology Co., Ltd.
Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and cleaning detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. was established in 2007 and is headquartered in Taoyuan City, Taiwan.
Full company profileSea Mild Biotechnology Co., Ltd. financial statements
Sea Mild Biotechnology Co., Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 228M | 168M | 215M | 214M | 208M | 164M | 203M | 257M | 319M | 342M |
| Gross Profit | 54.5M | 26.9M | 57.0M | 2.90M | 22.9M | 13.0M | 28.1M | 56.4M | 91.3M | 89.2M |
| Operating Income | -33.4M | -30.6M | -7.60M | -103M | -36.6M | -32.0M | -12.0M | 4.83M | 22.3M | 7.22M |
| EBITDA | -26.3M | 22.3M | -2.34M | -121M | -25.2M | -20.3M | -5.63M | 21.6M | 53.2M | 34.7M |
| Net Income | -29.8M | 17.8M | 66.0K | -159M | -55.5M | -52.1M | -21.4M | 6.19M | 32.0M | 8.84M |
| EPS | -1.93 | 1.15 | 0.00 | -8.34 | -2.87 | -2.70 | -1.11 | 0.32 | 1.66 | 0.46 |
| Balance Sheet | ||||||||||
| Total Assets | 318M | 338M | 315M | 363M | 249M | 168M | 158M | 190M | 256M | 326M |
| Total Liabilities | 190M | 191M | 111M | 171M | 111M | 82.4M | 93.2M | 120M | 154M | 215M |
| Shareholders' Equity | 127M | 147M | 204M | 192M | 138M | 85.8M | 64.5M | 70.4M | 102M | 111M |
| Cash & Short-term Investments | 16.2M | 13.7M | 89.3M | 50.2M | 55.6M | 38.9M | 47.6M | 56.5M | 91.7M | 89.2M |
| Total Debt | 117M | 138M | 51.4M | 64.6M | 40.4M | 31.6M | 30.3M | 55.0M | 70.0M | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -52.0M | -53.3M | -26.9M | -63.3M | 4.48M | -12.4M | 11.7M | 8.84M | 34.3M | 7.63M |
| Capital Expenditure | 9.88M | 3.50M | 12.4M | 45.4M | 16.7M | 3.40M | 326K | 1.25M | 11.4M | 15.0M |
| Free Cash Flow | -61.9M | -56.8M | -39.3M | -109M | -14.1M | -15.8M | 12.9M | 7.59M | 22.8M | -7.39M |
| Ratios | ||||||||||
| ROE | -23.4% | 12.1% | 0.0% | -82.8% | -40.3% | -60.7% | -33.2% | 8.8% | 31.2% | 8.0% |
| ROA | -9.4% | 5.3% | 0.0% | -43.8% | -22.3% | -30.9% | -13.6% | 3.3% | 12.5% | 2.7% |
| Net Profit Margin | -13.1% | 10.6% | 0.0% | -74.3% | -26.7% | -31.8% | -10.6% | 2.4% | 10.0% | 2.6% |
| Debt to Equity | 0.92x | 0.94x | 0.25x | 0.34x | 0.29x | 0.37x | 0.47x | 0.78x | 0.68x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sea Mild Biotechnology Co., Ltd. dividends
Sea Mild Biotechnology Co., Ltd. has not paid dividends in the last 10 fiscal years.
Last stock split: 769.28:1000 on Jan 21, 2021.
Who owns Sea Mild Biotechnology Co., Ltd.
Ownership data of Sea Mild Biotechnology Co., Ltd. is not available yet.
Sea Mild Biotechnology Co., Ltd. company profile
- Company name
- Sea Mild Biotechnology Co., Ltd.
- Ticker
- 7516.TWO
- ISIN
- TW0007516B19
- Exchange
- Taiwan OTC Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Fiscal year end
- December
- Address
- No. 43, Guanye East Road, Taoyuan City, Taiwan, 324017
- Phone
- 886 3 468 8698
- Website
- seamild.com.tw
About Sea Mild Biotechnology Co., Ltd.
Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and cleaning detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. was established in 2007 and is headquartered in Taoyuan City, Taiwan.
Sea Mild Biotechnology Co., Ltd. management
2- Mr. Yunjun LuoChairman & Manager
- Ms. Yufen WeiAccounting Supervisor